AU5556698A - Method for producing metal complex carboxylic acid amides - Google Patents

Method for producing metal complex carboxylic acid amides

Info

Publication number
AU5556698A
AU5556698A AU55566/98A AU5556698A AU5556698A AU 5556698 A AU5556698 A AU 5556698A AU 55566/98 A AU55566/98 A AU 55566/98A AU 5556698 A AU5556698 A AU 5556698A AU 5556698 A AU5556698 A AU 5556698A
Authority
AU
Australia
Prior art keywords
carboxylic acid
metal complex
complex carboxylic
acid amides
producing metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55566/98A
Inventor
Klaus-Dieter Graske
Johannes Dr. Platzek
Bernd Dr. Raduchel
Heribert Schmitt-Willich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5556698A publication Critical patent/AU5556698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/143—Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to a method for producing metal complex carboxylic acid amides characterized in that a metal complex carboxylic acid mixture consisting of metal complex carboxylic acid and at least one solubilizing substance is pretreated in dimethylsulfoxide (DSMO) with a dehydrating reagent, optionally by adding a coupling adjuvant and made to react with a amine of general formula (I): A(NH2)n, wherein A means the radical of a natural or synthetic amine and n stands for the figures 1 to 100.
AU55566/98A 1996-12-04 1997-11-26 Method for producing metal complex carboxylic acid amides Abandoned AU5556698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19652386 1996-12-04
DE19652386A DE19652386A1 (en) 1996-12-04 1996-12-04 Process for the preparation of metal complex carboxamides
PCT/EP1997/006594 WO1998024775A1 (en) 1996-12-04 1997-11-26 Method for producing metal complex carboxylic acid amides

Publications (1)

Publication Number Publication Date
AU5556698A true AU5556698A (en) 1998-06-29

Family

ID=7814928

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55566/98A Abandoned AU5556698A (en) 1996-12-04 1997-11-26 Method for producing metal complex carboxylic acid amides

Country Status (12)

Country Link
EP (1) EP0946525B1 (en)
JP (1) JP4278182B2 (en)
AT (1) ATE263758T1 (en)
AU (1) AU5556698A (en)
DE (2) DE19652386A1 (en)
DK (1) DK0946525T3 (en)
ES (1) ES2218711T3 (en)
NO (1) NO312724B1 (en)
PT (1) PT946525E (en)
TW (1) TW438804B (en)
WO (1) WO1998024775A1 (en)
ZA (1) ZA9710930B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19905094C1 (en) * 1999-02-01 2000-10-12 Schering Ag Gadolinium (III) complexes and their use for two-step forms of radiation therapy and pharmaceutical compositions containing them
DE10105014C2 (en) * 2001-01-26 2003-03-27 Schering Ag New process for the production of DTPA monoamides
FR2856063B1 (en) * 2003-06-13 2005-10-07 Air Liquide PROCESS FOR THE PREPARATION OF CIS-8B-METHYLDECAHYDRO-2A, 4A, 6A, 8A-TETRAAZACYCLOPENTA [FG] ACENAPHTHYLENE, OR CIS-DECAHYDRO-2A, 4A, 6A, 8A-TETRAAZACYCLOPENTA [FG] ACENAPHTHYLENE, CYCLENE, AND CYCLENES FUNCTIONALISED
DE102007002726A1 (en) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft New cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
DE102007058220A1 (en) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors
KR101334780B1 (en) 2010-08-13 2013-12-02 한국생명공학연구원 Iodine-containing radial-shape macromolecular compounds, preparation method thereof and contrast medium compositions for CT comprising the same
CN105189521A (en) 2013-02-12 2015-12-23 拜耳医药股份公司 Metal chelate compounds for binding to the platelet specific glycoprotein IIb/IIIa
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3544964B1 (en) 2016-11-28 2020-06-17 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
AU2019382881A1 (en) 2018-11-23 2021-05-20 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
CN111004623B (en) * 2019-12-20 2023-07-18 河北科技大学 Porphyrin fluorescent material and preparation method thereof
EP4360660A1 (en) 2022-10-24 2024-05-01 Bayer AG Process for the preparation of a gadolinium contrast agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
DE3625417C2 (en) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecane derivatives
DE4218744C2 (en) * 1992-06-04 1997-11-06 Schering Ag Process for the preparation of N-β-hydroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and their metal complexes

Also Published As

Publication number Publication date
PT946525E (en) 2004-08-31
JP4278182B2 (en) 2009-06-10
TW438804B (en) 2001-06-07
EP0946525B1 (en) 2004-04-07
ATE263758T1 (en) 2004-04-15
NO992710D0 (en) 1999-06-03
EP0946525A1 (en) 1999-10-06
ZA9710930B (en) 1998-09-08
DE19652386A1 (en) 1998-06-10
ES2218711T3 (en) 2004-11-16
DK0946525T3 (en) 2004-08-02
JP2001504844A (en) 2001-04-10
WO1998024775A1 (en) 1998-06-11
DE59711504D1 (en) 2004-05-13
NO312724B1 (en) 2002-06-24
NO992710L (en) 1999-06-03

Similar Documents

Publication Publication Date Title
AU5556698A (en) Method for producing metal complex carboxylic acid amides
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
KR100222606B1 (en) Process for preparation of beta-lactams
MX9700565A (en) PROCESS FOR PREPARATION OF 'beta'-LACTAMS AT CONSTANTLY HIGH CONCENTRATION OF REACTANTS.
TW258728B (en)
DK0619305T3 (en) Lactone Compound and Method of Preparation thereof
NZ514653A (en) Process for producing an amide compound by reacting a compound with an amino group with a polyaminocarboxylic acid anhydride
DE3375569D1 (en) Improvement in the process for preparing biaryl compounds via coupling of an arylamine with an arene
AU7206898A (en) Method for producing 1,3-di-substituted 2-nitroguanidines
IL141010A0 (en) Method for producing atropic acid ethyl ester
DE9116462U1 (en)
HU9403715D0 (en) A process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
MXPA05006279A (en) Process for the preparation of pregnanes.
IL105657A (en) Process for the preparation of 5-chloroxindole
UA70975C2 (en) 1,4-diaryl-2-fluoro-1-buten-3-ol derivatives, a method for the preparation thereof and methods for the preparation of derivatives of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl -2-fluoro-2-buten
UA7148C2 (en) Process for tetrakisazodyes preparation
BG49656A1 (en) Imidazolcontaines esters n- substituted carbaitde acids and method for their preparing
YU78793A (en) N-CYCLOALKYL AMIDES OF PRIVALIC ACID AND THE PROCEDURE FOR OBTAINING THEM
UA28209A (en) Method for insulation of stratal water inflow to well
UA41330C2 (en) process for the preparation of dissolved acetylene